NAGIOS: RODERIC FUNCIONANDO

Duloxetina: un antidepresivo con numerosas posibilidades terapéuticas

DSpace Repository

dc.contributor.author	Sierra, Pilar
dc.date.accessioned	2022-10-28T09:54:37Z
dc.date.available	2022-10-28T09:54:37Z
dc.date.issued	2022
dc.identifier.uri	https://hdl.handle.net/10550/84314
dc.description.abstract	Duloxetine is a dual action antidepressant included in the pharmacological class of serotonin-norepinephrine reuptake inhibitors. Its mechanism of action makes it a drug indicated for the treatment of clinical conditions than frequently coexist and share pathophysiological pathways such as major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, or chronic musculoskeletal pain. It is also indicated in other diseases that reduce quality of life such as chemotherapy induced peripheral neuropathy or stress urinary incontinence. All this with a favorable side effect profile. In this review, we will elucidate current evidences on the use of duloxetine in the treatment of these diseases and its use in special populations.
dc.language.iso	spa
dc.relation.ispartof	Kranion, 2022, vol. 17, num. 1, p. 10-14
dc.source	Sierra, Pilar 2022 Duloxetina: un antidepresivo con numerosas posibilidades terapéuticas Kranion 17 1 10 14
dc.subject	Psiquiatria
dc.title	Duloxetina: un antidepresivo con numerosas posibilidades terapéuticas
dc.type	journal article	es_ES
dc.date.updated	2022-10-28T09:54:38Z
dc.identifier.doi	https://doi.org/10.24875/KRANION.M22000032
dc.identifier.idgrec	154362
dc.rights.accessRights	open access	es_ES